Moderna Inc

$53.08
(as of Oct 25, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Moderna Inc

Stock Price
$53.09
Ticker Symbol
MRNA
Exchange
NASDAQ

Industry Information for Moderna Inc

Sector
Healthcare
Industry
Biotechnology

Company Description for Moderna Inc

Country
USA
Full Time Employees
5,600

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Fundamentals for Moderna Inc

Market Capitalization
$20,522,895,360
EBITDA
$-4,107,000,064
Dividends per Share
P/E Ratio
Forward P/E Ratio
32.47
Earnings per Share
$-15.43
Earnings per Share Estimate Next Year
$-8.34
Profit Margin
-116.18%
Shares Outstanding
384,396,000
Percent Owned by Insiders
9.52%
Percent Owned by Institutions
72.12%
52-Week High
$170.47
52-Week Low
$52.26

Technical Indicators for Moderna Inc

50-Day Moving Average
$67.87
200-Day Moving Average
$101.54
RSI
24.02
2.37

Analyst Ratings for Moderna Inc

Strong Buy
5
Buy
3
Hold
15
Sell
2
Strong Sell
0

News About Moderna Inc

Oct 21, 2024, 1:45 PM EST
Moderna Gets Sued by Northwestern University Over Patents Related to COVID Vaccines See more.
Oct 20, 2024, 2:17 PM EST
We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts.In this article, we are going to take a look at where Moderna Inc. See more.
Oct 19, 2024, 11:19 AM EST
We recently compiled a list of the 10 Worst Performing NASDAQ Stocks in 2024. See more.
Oct 18, 2024, 3:26 PM EST
We recently published a list of 10 Best Medical Stocks to Buy Now. See more.
Oct 18, 2024, 3:26 PM EST
We recently published a list of 10 Best Medical Stocks to Buy Now. See more.